Kevin Fischbeck
Stock Analyst at B of A Securities
(4.08)
# 511
Out of 4,935 analysts
173
Total ratings
67.21%
Success rate
5.96%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Neutral | $300 → $290 | $250.89 | +15.59% | 24 | Jul 30, 2025 | |
| ARDT Ardent Health | Downgrades: Underperform | $16 → $15 | $11.89 | +22.79% | 3 | Jul 16, 2025 | |
| CNC Centene | Downgrades: Underperform | $52 → $30 | $25.59 | +17.23% | 13 | Jul 16, 2025 | |
| UHS Universal Health Services | Downgrades: Underperform | $215 → $185 | $172.30 | +7.37% | 15 | Jul 16, 2025 | |
| HCA HCA Healthcare | Downgrades: Neutral | $394 → $410 | $381.61 | +7.44% | 11 | Jul 16, 2025 | |
| HUM Humana | Maintains: Neutral | $320 → $260 | $266.68 | -2.50% | 15 | Jun 17, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $165 → $180 | $165.58 | +8.71% | 5 | May 14, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Buy | $50 → $45 | $19.24 | +131.29% | 6 | Feb 28, 2025 | |
| AMN AMN Healthcare Services | Downgrades: Underperform | $65 → $48 | $17.24 | +178.42% | 4 | Oct 7, 2024 | |
| AGL agilon health | Downgrades: Underperform | $3 | $0.87 | +243.41% | 2 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $139 → $145 | $129.50 | +11.97% | 12 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $646 → $530 | $293.99 | +80.28% | 3 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $156.90 | +179.80% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $9.19 | -29.27% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $14.51 | -50.03% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $274.90 | +27.32% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $23.67 | +90.11% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $74 | $117.58 | -37.06% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $2.49 | +120.88% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $12.07 | +189.98% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $2.18 | +358.72% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $12.74 | -41.11% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $28.21 | -36.19% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $14.33 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $30.27 | -37.23% | 2 | Feb 9, 2018 |
UnitedHealth Group
Jul 30, 2025
Maintains: Neutral
Price Target: $300 → $290
Current: $250.89
Upside: +15.59%
Ardent Health
Jul 16, 2025
Downgrades: Underperform
Price Target: $16 → $15
Current: $11.89
Upside: +22.79%
Centene
Jul 16, 2025
Downgrades: Underperform
Price Target: $52 → $30
Current: $25.59
Upside: +17.23%
Universal Health Services
Jul 16, 2025
Downgrades: Underperform
Price Target: $215 → $185
Current: $172.30
Upside: +7.37%
HCA Healthcare
Jul 16, 2025
Downgrades: Neutral
Price Target: $394 → $410
Current: $381.61
Upside: +7.44%
Humana
Jun 17, 2025
Maintains: Neutral
Price Target: $320 → $260
Current: $266.68
Upside: -2.50%
Tenet Healthcare
May 14, 2025
Maintains: Buy
Price Target: $165 → $180
Current: $165.58
Upside: +8.71%
Acadia Healthcare Company
Feb 28, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $19.24
Upside: +131.29%
AMN Healthcare Services
Oct 7, 2024
Downgrades: Underperform
Price Target: $65 → $48
Current: $17.24
Upside: +178.42%
agilon health
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $0.87
Upside: +243.41%
Aug 7, 2024
Maintains: Underperform
Price Target: $139 → $145
Current: $129.50
Upside: +11.97%
Jul 18, 2024
Downgrades: Neutral
Price Target: $646 → $530
Current: $293.99
Upside: +80.28%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $156.90
Upside: +179.80%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $9.19
Upside: -29.27%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $14.51
Upside: -50.03%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $274.90
Upside: +27.32%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $23.67
Upside: +90.11%
Apr 28, 2023
Maintains: Buy
Price Target: $69 → $74
Current: $117.58
Upside: -37.06%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $2.49
Upside: +120.88%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $12.07
Upside: +189.98%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $2.18
Upside: +358.72%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $12.74
Upside: -41.11%
Jun 24, 2020
Initiates: Buy
Price Target: $18
Current: $28.21
Upside: -36.19%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $14.33
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $30.27
Upside: -37.23%